Keishibukuryogan (gui-zhi-fu-ling-wan), a Kampo Formula, Decreases Disease Activity and Soluble Vascular Adhesion Molecule-1 in Patients with Rheumatoid Arthritis

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2006 Sep 5

PMID 16951720

Citations 19

Authors

Kazuya Nozaki

Hiroaki Hikiami

Hirozo Goto

Takako Nakagawa

Naotoshi Shibahara

Yutaka Shimada

Affiliations

Soon will be listed here.

Abstract

An increasing death rate due to cardiovascular disease in patients with rheumatoid arthritis (RA) has been reported. Keishibukuryogan (KBG) is a traditional Chinese/Japanese (Kampo) formula that has been administered to patients with blood stagnation, e.g. thrombotic disease and atherosclerosis. The objective of this study was to evaluate the efficacy of KBG on disease activity and endothelial dysfunction in RA patients. Sixteen RA patients were enrolled and administered KBG (12 g per day) for 12 weeks in addition to continuing other drugs. The disease activity of RA was assessed by modified disease activity scores for 28 joints (DAS(28)). Plasma levels of adhesion molecules, soluble E-selectin (sE-selectin), soluble intercellular adhesion molecule-1 (sICAM-1) and soluble vascular cell adhesion molecule-1 (sVCAM-1) were evaluated. C-reactive protein (CRP), inflammatory cytokines (IL-1beta, IL-6 and TNF-alpha) and lipid peroxide (LPO) were also evaluated. Fourteen patients completed the study. The disease activity of RA, tender joint count, swollen joint count and DAS(28) decreased significantly. Among adhesion molecules, only sVCAM-1 decreased significantly. LPO also decreased significantly, whereas CRP and inflammatory cytokines remained unchanged. These results suggest that KBG has insufficient anti-inflammatory or immunomodulating effect but does have a beneficial effect on articular symptoms and a protective effect against endothelial dysfunction in RA patients.

Citing Articles

The Multiple Pharmacologic Functions and Mechanisms of Action of Guizhi Fuling Formulation.

Gao J, Yang J, Lu Z, Dong X, Xu Y Evid Based Complement Alternat Med. 2022; 2022:6813421.

PMID: 35529925 PMC: 9076289. DOI: 10.1155/2022/6813421.

A Review on the Mechanism and Application of Keishibukuryogan.

Tanaka K, Chiba K, Nara K Front Nutr. 2022; 8:760918.

PMID: 35004802 PMC: 8740291. DOI: 10.3389/fnut.2021.760918.

Phytochemistry and Pharmacological Activities of (F.A. Wolf) Ryvarden & Gilb.

Nie A, Chao Y, Zhang X, Jia W, Zhou Z, Zhu C Front Pharmacol. 2020; 11:505249.

PMID: 33071776 PMC: 7533546. DOI: 10.3389/fphar.2020.505249.

Effectiveness of Gyejibongnyeong-Hwan for shoulder pain: study protocol for a randomised, wait-list controlled pilot trial.

Jang S, Sung H, Ko M, Shin S, Go H, Jung J Trials. 2020; 21(1):193.

PMID: 32066487 PMC: 7027269. DOI: 10.1186/s13063-020-4092-y.

Understanding the Role of Gui-Zhi-Fu-Ling-Capsules (Chinese Medicine) for Treatment of Endometriosis in the Rat Model: Using NMR Based Metabolomics.

Zhou J, Ding Z, Hardiman P Evid Based Complement Alternat Med. 2019; 2018:9864963.

PMID: 30662514 PMC: 6313965. DOI: 10.1155/2018/9864963.

References

del Rincon I, Williams K, Stern M, Freeman G, Escalante A . High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2002; 44(12):2737-45. DOI: 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-%23. View

Blankenberg S, Barbaux S, Tiret L . Adhesion molecules and atherosclerosis. Atherosclerosis. 2003; 170(2):191-203. DOI: 10.1016/s0021-9150(03)00097-2. View

Davies M, Gordon J, Gearing A, Pigott R, Woolf N, Katz D . The expression of the adhesion molecules ICAM-1, VCAM-1, PECAM, and E-selectin in human atherosclerosis. J Pathol. 1993; 171(3):223-9. DOI: 10.1002/path.1711710311. View

Klimiuk P, Sierakowski S, Latosiewicz R, Cylwik J, Cylwik B, Skowronski J . Soluble adhesion molecules (ICAM-1, VCAM-1, and E-selectin) and vascular endothelial growth factor (VEGF) in patients with distinct variants of rheumatoid synovitis. Ann Rheum Dis. 2002; 61(9):804-9. PMC: 1754213. DOI: 10.1136/ard.61.9.804. View

Kamanli A, Naziroglu M, Aydilek N, Hacievliyagil C . Plasma lipid peroxidation and antioxidant levels in patients with rheumatoid arthritis. Cell Biochem Funct. 2003; 22(1):53-7. DOI: 10.1002/cbf.1055. View

Price D, Loscalzo J . Cellular adhesion molecules and atherogenesis. Am J Med. 1999; 107(1):85-97. DOI: 10.1016/s0002-9343(99)00153-9. View

OBrien K, Allen M, McDonald T, Chait A, Harlan J, Fishbein D . Vascular cell adhesion molecule-1 is expressed in human coronary atherosclerotic plaques. Implications for the mode of progression of advanced coronary atherosclerosis. J Clin Invest. 1993; 92(2):945-51. PMC: 294934. DOI: 10.1172/JCI116670. View

Klimiuk P, Sierakowski S, Domyslawska I, Fiedorczyk M, Chwiecko J . Reduction of soluble adhesion molecules (sICAM-1, sVCAM-1, and sE-selectin) and vascular endothelial growth factor levels in serum of rheumatoid arthritis patients following multiple intravenous infusions of infliximab. Arch Immunol Ther Exp (Warsz). 2004; 52(1):36-42. View

Prevoo M, van t Hof M, Kuper H, van Leeuwen M, van de Putte L, van Riel P . Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995; 38(1):44-8. DOI: 10.1002/art.1780380107. View

10.

Desideri G, Marinucci M, Tomassoni G, Masci P, Santucci A, Ferri C . Vitamin E supplementation reduces plasma vascular cell adhesion molecule-1 and von Willebrand factor levels and increases nitric oxide concentrations in hypercholesterolemic patients. J Clin Endocrinol Metab. 2002; 87(6):2940-5. DOI: 10.1210/jcem.87.6.8545. View

11.

Tokuhira M, Hosaka S, Volin M, Haines 3rd G, Katschke Jr K, Kim S . Soluble vascular cell adhesion molecule 1 mediation of monocyte chemotaxis in rheumatoid arthritis. Arthritis Rheum. 2000; 43(5):1122-33. DOI: 10.1002/1529-0131(200005)43:5<1122::AID-ANR23>3.0.CO;2-7. View

12.

Ozturk H, Cimen M, Cimen O, Kacmaz M, Durak I . Oxidant/antioxidant status of plasma samples from patients with rheumatoid arthritis. Rheumatol Int. 2000; 19(1-2):35-7. DOI: 10.1007/s002960050097. View

13.

Helmy M, Shohayeb M, Helmy M, El-Bassiouni E . Antioxidants as adjuvant therapy in rheumatoid disease. A preliminary study. Arzneimittelforschung. 2001; 51(4):293-8. DOI: 10.1055/s-0031-1300040. View

14.

De Caterina R, Basta G, Lazzerini G, DellOmo G, Petrucci R, Morale M . Soluble vascular cell adhesion molecule-1 as a biohumoral correlate of atherosclerosis. Arterioscler Thromb Vasc Biol. 1997; 17(11):2646-54. DOI: 10.1161/01.atv.17.11.2646. View

15.

Dessein P, Joffe B, Singh S . Biomarkers of endothelial dysfunction, cardiovascular risk factors and atherosclerosis in rheumatoid arthritis. Arthritis Res Ther. 2005; 7(3):R634-43. PMC: 1174955. DOI: 10.1186/ar1717. View

16.

Hikiami H, Goto H, Sekiya N, Hattori N, Sakakibara I, Shimada Y . Comparative efficacy of Keishi-bukuryo-gan and pentoxifylline on RBC deformability in patients with "oketsu" syndrome. Phytomedicine. 2003; 10(6-7):459-66. DOI: 10.1078/094471103322331395. View

17.

Kitani A, Nakashima N, Izumihara T, Inagaki M, Baoui X, Yu S . Soluble VCAM-1 induces chemotaxis of Jurkat and synovial fluid T cells bearing high affinity very late antigen-4. J Immunol. 1998; 161(9):4931-8. View

18.

Sekiya N, Tanaka N, Itoh T, Shimada Y, Goto H, Terasawa K . Keishi-bukuryo-gan prevents the progression of atherosclerosis in cholesterol-fed rabbit. Phytother Res. 1999; 13(3):192-6. DOI: 10.1002/(SICI)1099-1573(199905)13:3<192::AID-PTR412>3.0.CO;2-2. View

19.

Goto H, Shimada Y, Akechi Y, Kohta K, Hattori M, Terasawa K . Endothelium-dependent vasodilator effect of extract prepared from the roots of Paeonia lactiflora on isolated rat aorta. Planta Med. 1996; 62(5):436-9. DOI: 10.1055/s-2006-957934. View

20.

van Dinther-Janssen A, Horst E, Koopman G, Newmann W, Scheper R, Meijer C . The VLA-4/VCAM-1 pathway is involved in lymphocyte adhesion to endothelium in rheumatoid synovium. J Immunol. 1991; 147(12):4207-10. View